首页> 外文OA文献 >Evaluation of splenic embolization in patients with portal hypertension and hypersplenism.
【2h】

Evaluation of splenic embolization in patients with portal hypertension and hypersplenism.

机译:评价门静脉高压症和脾功能亢进患者的脾栓塞。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Twenty-five patients with hypersplenism caused by portal hypertension were treated by repeated partial splenic embolization. Fourteen surviving patients were followed for up to six years showing a good response on peripheral blood count and bleeding tendency. Three patients died in connection with the treatment and another eight died within half a year because of the underlying liver disease. The discomfort and complications of fever, pain, pleural effusion, and abscess formation and the possibility to avoid these by repeated partial embolization under antibiotic cover are discussed. The results are compared with reports in the reviewed actual literature and the splenic embolization is given a place among the means of a successful selective symptomatic treatment of partial hypertension.
机译:25例门静脉高压症所致脾功能亢进的患者,经反复部分脾栓塞治疗。对十四名幸存的患者进行了长达六年的随访,结果显示他们对外周血细胞计数和出血趋势有良好的反应。与该治疗有关的三名患者死亡,半年内又有八名患者死于潜在的肝脏疾病。讨论了发烧,疼痛,胸腔积液和脓肿形成的不适和并发症,以及通过在抗生素覆盖下反复进行局部栓塞术避免这些并发症的可能性。将结果与回顾的实际文献中的报告进行比较,并在成功的选择性对症治疗中对脾动脉栓塞进行了研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号